Clinical Trial: Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Observational

Official Title: Novel Diagnostics With Optical Coherence Tomography: Imaging of the Anterior Eye

Brief Summary: The purpose of this research is to evaluate the optical coherence tomography (OCT), to image diseases of the eye. OCT may be useful for the early diagnosis and monitoring of a variety of diseases involving the eye, such as Fuch's Dystrophy (type of eye disease) and retinal damage (eye diseases in the back of the eye) due to diabetes.

Detailed Summary: The purpose of this research is to evaluate the optical coherence tomography (OCT), to image diseases of the eye. OCT may be useful for the early diagnosis and monitoring of a variety of diseases involving the eye, such as Fuch's Dystrophy (type of eye disease) and retinal damage (eye diseases in the back of the eye) due to diabetes. OCT may also be useful for assessing contact lens and surgical procedures, such as LASIK (type of ophthalmic surgical procedure). The OCT is Food and Drug Administration (FDA) approved. The ultra high OCT is a non-significant risk device (it does not present a possible serious risk to your health, your safety, or your welfare) that has not been approved by the FDA. This study will also be conducted at the Massachusetts Institute of Technology and Tufts-New England Medical Center New England Eye Center in Massachusetts
Sponsor: New York University School of Medicine

Current Primary Outcome: Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye [ Time Frame: 2 years ]

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: New York University School of Medicine

Dates:
Date Received: June 19, 2006
Date Started: October 2005
Date Completion: January 2020
Last Updated: February 10, 2017
Last Verified: February 2017